|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Exact Sciences Corporation |
EXAS |
30063P105 |
684 |
$69,939.00 |
3.32% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
705 |
$64,740.15 |
3.08% |
| Penumbra, Inc. |
PEN |
70975L107 |
153 |
$54,931.59 |
2.61% |
| Align Technology, Inc. |
ALGN |
016255101 |
317 |
$52,279.64 |
2.48% |
| Revvity, Inc. |
RVTY |
714046109 |
452 |
$50,230.76 |
2.39% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$48,669.58 |
2.31% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
93 |
$48,549.72 |
2.31% |
| The Cooper Companies, Inc. |
COO |
216648501 |
583 |
$46,919.84 |
2.23% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
76 |
$46,209.52 |
2.20% |
| Waters Corporation |
WAT |
941848103 |
120 |
$46,203.60 |
2.19% |
| DexCom, Inc. |
DXCM |
252131107 |
612 |
$44,896.32 |
2.13% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,917 |
$44,871.68 |
2.13% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
369 |
$44,856.67 |
2.13% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
562 |
$44,544.12 |
2.12% |
| Alcon Inc. |
ALC.SW |
H01301128 |
552 |
$44,352.36 |
2.11% |
| Danaher Corporation |
DHR |
235851102 |
197 |
$44,234.38 |
2.10% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
539 |
$44,122.54 |
2.10% |
| Hologic, Inc. |
HOLX |
436440101 |
589 |
$44,233.90 |
2.10% |
| Steris Plc |
STE |
G8473T100 |
169 |
$44,085.34 |
2.09% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
31 |
$43,450.84 |
2.06% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
184 |
$43,409.69 |
2.06% |
| Becton, Dickinson and Company |
BDX |
075887109 |
214 |
$43,210.88 |
2.05% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,452 |
$42,338.57 |
2.01% |
| Medtronic Plc |
MDT |
G5960L103 |
418 |
$42,130.22 |
2.00% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
505 |
$40,652.50 |
1.93% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,785 |
$40,549.28 |
1.93% |
| Cochlear Limited |
COH.AU |
Q25953102 |
215 |
$40,448.15 |
1.92% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
147 |
$40,402.80 |
1.92% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
134 |
$40,171.86 |
1.91% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,129 |
$39,991.20 |
1.90% |
| Agilent Technologies, Inc. |
A |
00846U101 |
292 |
$39,090.04 |
1.86% |
| Boston Scientific Corporation |
BSX |
101137107 |
418 |
$39,204.22 |
1.86% |
| Stryker Corporation |
SYK |
863667101 |
109 |
$39,003.47 |
1.85% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
455 |
$38,829.09 |
1.84% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,240 |
$38,457.71 |
1.83% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,263 |
$38,318.36 |
1.82% |
| Masimo Corporation |
MASI |
574795100 |
276 |
$37,996.92 |
1.80% |
| ResMed Inc. |
RMD |
761152107 |
147 |
$37,884.84 |
1.80% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
2,331 |
$37,061.42 |
1.76% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
729 |
$36,983.80 |
1.76% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
421 |
$36,083.91 |
1.71% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
152 |
$35,855.28 |
1.70% |
| Baxter International Inc. |
BAX |
071813109 |
1,817 |
$35,631.37 |
1.69% |
| BioMerieux |
BIM.FP |
F1149Y232 |
300 |
$35,585.43 |
1.69% |
| Teleflex Incorporated |
TFX |
879369106 |
334 |
$35,180.22 |
1.67% |
| Insulet Corporation |
PODD |
45784P101 |
127 |
$32,791.40 |
1.56% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,460 |
$32,423.25 |
1.54% |
| Abbott Laboratories |
ABT |
002824100 |
301 |
$31,921.05 |
1.52% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,234 |
$30,837.81 |
1.46% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
805 |
$27,694.28 |
1.32% |
| US Dollar |
$USD |
|
2,738 |
$2,737.77 |
0.13% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|